Skip to main content
logo
Energenesis Biomedical CO.,LTD. (TPE:6657)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.40
-0.85 (-2.81%)
Jul 30, 2026, 1:30 PM CST

TPE:6657 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.857.677.757.167.357.49
Revenue Growth
3.94%-0.97%8.26%-2.63%-1.84%5.76%
Gross Profit
5.895.835.695.235.175.36
Operating Income
-225.28-275.28-255.17-261.84-271.65-122.09
Net Income
-207.74-258.4-231.08-260.38-265.66-120.24
Earnings Per Share
-2.35-2.92-3.03-3.62-3.99-2.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
775.63838.1664.98699.2484.67725.84
Total Debt
13.314.8410.038.289.5411.94
Net Cash (Debt)
762.33823.26654.95690.92475.13713.91
Net Cash Growth
-23.43%25.70%-5.21%45.41%-33.45%34.96%
Net Cash Per Share
8.619.318.589.597.1311.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-156.41-222.41-180.71-225.05-232.84-97.29
Capital Expenditures
-2.67-2.31-0.75-0.84-6.45-8.9
Free Cash Flow
-159.08-224.72-181.47-225.89-239.29-106.18
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
75.06%76.00%73.43%73.02%70.26%71.56%
Operating Margin
-2869.09%-3587.11%-3292.93%-3657.96%-3695.47%-1630.26%
Pretax Margin
-2645.66%-3367.24%-2982.06%-3637.64%-3613.98%-1605.50%
Profit Margin
-2645.66%-3367.24%-2982.06%-3637.64%-3613.98%-1605.50%
FCF Margin
-2025.96%-2928.30%-2341.79%-3155.81%-3255.16%-1417.84%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
338.67496.78499.70641.51388.74400.14